Invitae Corp. (NVTA)

24.47
0.01 0.04
NYSE : Health Services
Prev Close 24.48
Open 24.72
Day Low/High 23.83 / 24.73
52 Wk Low/High 7.73 / 26.77
Volume 1.36M
Avg Volume 1.73M
Exchange NYSE
Shares Outstanding 93.70M
Market Cap 2.27B
EPS -1.90
P/E Ratio N/A
Div & Yield N.A. (N.A)
3 Small Biotechs to Watch as Earnings Season Winds Down

3 Small Biotechs to Watch as Earnings Season Winds Down

One already is up nicely on its results, while the other two should issue reports of interest in the next few days.

Invitae To Present At The 8th Annual SVB Leerink Global Healthcare Conference

Invitae To Present At The 8th Annual SVB Leerink Global Healthcare Conference

SAN FRANCISCO, Feb. 13, 2019 /PRNewswire/ --  Invitae Corporation (NYSE: NVTA), a leading genetics company, today announced that Sean George, co-founder and chief executive officer of Invitae, will present at the 8th Annual SVB Leerink Global Healthcare...

Invitae Launches Non-Invasive Prenatal Screening (NIPS), Offering In-Depth Genetic Information In Early Pregnancy

Invitae Launches Non-Invasive Prenatal Screening (NIPS), Offering In-Depth Genetic Information In Early Pregnancy

-- In Combination with Carrier Screening, NIPS Provides Affordable, Streamlined Access to Genetic Testing for Parents-to-Be --

New Study Finds Disease-Causing Variants More Common In Men With Prostate Cancer Than Previously Thought

New Study Finds Disease-Causing Variants More Common In Men With Prostate Cancer Than Previously Thought

-- Largest Dataset of Prostate Cancer Patients Shows 17% Have Increased Risk Based on Genetic Analysis --

Invitae To Announce Fourth Quarter And Year-end 2018 Financial Results On February 19, 2019

Invitae To Announce Fourth Quarter And Year-end 2018 Financial Results On February 19, 2019

SAN FRANCISCO, Jan. 29, 2019 /PRNewswire/ -- Invitae Corporation (NYSE: NVTA), the fastest growing clinical genetics company, today announced that it will report its fourth quarter and year-end 2018 financial results on Tuesday, February 19, 2019 and will...

The Earnings Super Bowl: Cramer's 'Mad Money' Recap (Friday 1/25/19)

The Earnings Super Bowl: Cramer's 'Mad Money' Recap (Friday 1/25/19)

Jim Cramer's plan for getting through the heart of earnings season next week.

Cronos, Fortinet and Dominion: 'Mad Money' Lightning Round

Cronos, Fortinet and Dominion: 'Mad Money' Lightning Round

Jim Cramer weighs in on Cronos, Fortinet, Dominion Energy and more.

First Week Of February 15th Options Trading For Invitae (NVTA)

First Week Of February 15th Options Trading For Invitae (NVTA)

Investors in Invitae Corp saw new options become available this week, for the February 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NVTA options chain for the new February 15th contracts and identified one put and one call contract of particular interest.

Invitae Is Now Oversold (NVTA)

Invitae Is Now Oversold (NVTA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Invitae Breaks Below 200-Day Moving Average - Notable For NVTA

Invitae Breaks Below 200-Day Moving Average - Notable For NVTA

In trading on Friday, shares of Invitae Corp crossed below their 200 day moving average of $10.05, changing hands as low as $9.44 per share. Invitae Corp shares are currently trading down about 9.7% on the day.

Here Are 3 Small-Cap Names for Biotech Investors to Consider

Here Are 3 Small-Cap Names for Biotech Investors to Consider

We look at a slightly riskier part of the sector...that should be able to reach profitability with little to no additional funding needs.

PayPal, Senseonomics, Idexx Laboratories: 'Mad Money' Lightning Round

PayPal, Senseonomics, Idexx Laboratories: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at PayPal, Senseonomics, Idexx Laboratories, Sonos, Denbury Resources, Apptio, Invitae, Wayfair, JD.com, and McDonald's.

The Truth About Trade: Cramer's 'Mad Money' Recap (Monday 9/17/18)

The Truth About Trade: Cramer's 'Mad Money' Recap (Monday 9/17/18)

Jim Cramer says Wall Street isn't very worried about tariffs. He highlights the stocks with China exposure and looks at the potential impact.

First Week Of June 2019 Options Trading For Invitae (NVTA)

First Week Of June 2019 Options Trading For Invitae (NVTA)

Investors in Invitae Corp saw new options begin trading this week, for the June 2019 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Interesting NVTA Put And Call Options For November 16th

Interesting NVTA Put And Call Options For November 16th

Investors in Invitae Corp saw new options become available this week, for the November 16th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NVTA options chain for the new November 16th contracts and identified one put and one call contract of particular interest.

Consider These Diagnostic Testing Firms

Consider These Diagnostic Testing Firms

Diagnostic firms can have an advantage of recurring revenue streams.

Names to Watch Amid Biotech's Nascent Rally

Names to Watch Amid Biotech's Nascent Rally

Progenics and Tesaro are among sagging small-cap biotech stocks that could rebound in coming months.

Invitae Reaches Analyst Target Price

Invitae Reaches Analyst Target Price

In recent trading, shares of Invitae Corp have crossed above the average analyst 12-month target price of $12.25, changing hands for $12.56/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

3 Small Biotechs Turn on the Revenue Jets

3 Small Biotechs Turn on the Revenue Jets

BioDelivery Sciences, Neos Therapeutics and Invitae Corp. are delivering big increases in sales.

Noteworthy Wednesday Option Activity: NVTA, SPA, ATI

Noteworthy Wednesday Option Activity: NVTA, SPA, ATI

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Invitae Corp , where a total volume of 6,054 contracts has been traded thus far today, a contract volume which is representative of approximately 605,400 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 77.8% of NVTA's average daily trading volume over the past month, of 778,605 shares.

Interesting NVTA Call Options For July 20th

Investors in Invitae Corp saw new options become available this week, for the July 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the NVTA options chain for the new July 20th contracts and identified the following call contract of particular interest.

3 of My Favorite Medical Diagnostic Plays

3 of My Favorite Medical Diagnostic Plays

These equities have been in rally mode since April.

3 Favorite Biotech Stocks for the Second Quarter

3 Favorite Biotech Stocks for the Second Quarter

Your questions are answered in our latest addition of the biotech mailbag.

Invitae Enters Oversold Territory (NVTA)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Notable Tuesday Option Activity: NVTA, INCY, SVU

Notable Tuesday Option Activity: NVTA, INCY, SVU

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Invitae Corp , where a total volume of 2,091 contracts has been traded thus far today, a contract volume which is representative of approximately 209,100 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 45% of NVTA's average daily trading volume over the past month, of 465,000 shares.

Relative Strength Alert For Invitae

Relative Strength Alert For Invitae

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Commit To Purchase Invitae Corp At $5, Earn 17.3% Annualized Using Options

Commit To Purchase Invitae Corp At $5, Earn 17.3% Annualized Using Options

Investors considering a purchase of Invitae Corp stock, but cautious about paying the going market price of $6.79/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the June put at the $5 strike, which has a bid at the time of this writing of 35 cents.

Short Interest In Invitae Makes 11.2% Move

Short Interest In Invitae Makes 11.2% Move

The most recent short interest data has been released for the 11/30/2017 settlement date, which shows a 345,791 share increase in total short interest for Invitae Corp , to 3,436,288, an increase of 11.19% since 11/15/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

RSI Alert: Invitae (NVTA) Now Oversold

RSI Alert: Invitae (NVTA) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Commit To Buy Invitae Corp At $7.50, Earn 18.6% Annualized Using Options

Commit To Buy Invitae Corp At $7.50, Earn 18.6% Annualized Using Options

Investors eyeing a purchase of Invitae Corp shares, but cautious about paying the going market price of $9.31/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March 2018 put at the $7.50 strike, which has a bid at the time of this writing of 70 cents.

TheStreet Quant Rating: D (Sell)